Clinical trial

Efficacy of an Early Intervention Programme Using Therapeutic Exercise in Patients With Plantar Fasciopathy

ID

Name

ProtocoloFP

Description

The aim of this project is to evaluate the efficacy of a therapeutic exercise programme in patients with plantar fasciitis applied early and aimed at strengthening the hip and foot musculature.

Trial arms

Trial start

2024-05-10

Estimated PCD

2024-05-10

Trial end

2025-02-10

Status

Not yet recruiting

Treatment

Muscle strengthening

Strengthening exercises for the intrinsic muscles of the foot and hips

Arms:

Experimental group

Standard treatment (oral analgesic/anti-inflammatory drug)

oral analgesic/anti-inflammatory drug. Education.

Arms:

Non-experimental group

Size

60

Primary endpoint

Pain intensity

It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Disability

It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

General health and health-related quality of life:

It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Physical activity

It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Overall perception of clinical change

It will be assessed at baseline and at 12 weeks (at the end of the intervention period), with a subsequent follow-up period at 3 and 6 months after the end of the intervention.

Eligibility criteria

Inclusion Criteria: * Patients with referred pain in the medial plantar area of the heel, accentuated with initial steps after a period of inactivity but also worsening after prolonged body weight bearing, of at least 3 months evolution prior to inclusion in the study. * Reproduction of the pain referred by the patient with palpation at the proximal insertion of the plantar fascia. Exclusion Criteria: * Pregnancy. * Injection of corticoids in the area in the 6 months prior to recruitment. * Previous illnesses that may alter gait (central or peripheral neurological pathology, degenerative and inflammatory arthropathies, systemic illnesses). * Existence of concomitant foot pathology (metatarsalgia, stress fractures, neuropathies due to entrapment, tendinitis, history of foot/ankle surgery, etc.). * People who do not have the capacity to understand and follow an exercise programme.

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Experimental study with random allocation of patients with similar characteristics to the control and intervention groups.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 60, 'type': 'ESTIMATED'}}

Updated at

2024-05-01

1 organization

1 product

1 indication

Organization

Universidad Miguel Hernandez de Elche

Product

Standard treatment

Indication

Plantar Fasciitis